SAA1 is highly expressed in lung cancer, gastric cancer, endometrial cancer, prostate cancer, melanoma, and esophagus cancer, which presented poor prognosis in patients (12, 13, 15, 19, 33, 34). The gene discussed is SAA1; the disease is prostate cancer.